⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14625817 | 0.74 | — | — | |
| SCHEMBL4610252 | 0.71 | — | — | |
| SCHEMBL1301753 | 0.70 | — | — | |
| SCHEMBL1301298 | 0.70 | — | — | |
| SCHEMBL1302131 | 0.70 | — | — | |
| SCHEMBL1301586 | 0.70 | — | — | |
| SCHEMBL9311918 | 0.70 | — | — | |
| SCHEMBL9178747 | 0.70 | — | — | |
| SCHEMBL16385700 | 0.67 | — | — | |
| SCHEMBL9503279 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2661266-B1 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ANJI PHARMA (US) LLC (US) | 2020-09-16 | — | — | EP | disclosed |